Peptide combinations for use in the diagnosis of schizophrenia
Abstract:
Provided is a composition including a combination of at least one short peptide and at least one peptide dimer, in defined ratio, to which autoantibodies found in elevated levels in schizophrenic patients bind.
Public/Granted literature
Information query
Patent Agency Ranking
0/0